> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Former Able Labs Quality Manager Debarred
- URL: https://www.fdaweb.com/former-able-labs-quality-manager-debarred/
- Published: 2018-09-28T12:00:00.000Z
- Updated: 2026-09-15T00:34:57.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142469

*Federal Register* notice: FDA has denied a request for a hearing from Dilip Patel and is issuing an order to debar Patel for five years from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases its order on a finding that Patel was convicted of a conspiracy to commit a felony under federal law for conduct relating to the regulation of a drug product. The notice says that in 2007, Patel pled guilty to one count of conspiracy to distribute misbranded and adulterated drugs. Subsequently, in 2010 the New Jersey District Court sentenced Patel to two years of probation. The conviction was related to his employment at Able Laboratories, Inc. (Able), where he was a quality control manager. According to the guilty plea, Patel supervised the falsification and manipulation of assay test results for atenolol, a prescription medication for cardiac conditions, and he directed a subordinate chemist to falsify and manipulate dissolution test results for methylphenidate hydrochloride extended-release tablets, a prescription medication for attention deficit and hyperactivity disorder. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-09-27/pdf/2018-20977.pdf?ref=fdaweb.com).